Diapharm GmbH press release
Moving to Diapharm: Former manager at Teva Martin Vortkamp takes over as Head of Business Development
Münster (Germany), 21 July 2009. Diapharm (www.diapharm.com) has hired Martin Vortkamp as manager of the Business Development division. He comes to the pharmaceutical service provider from Teva, where he was responsible for the portfolio and business development of the generics manufacturer. Martin Vortkamp's role at Diapharm will include driving forward internationalisation and development of new areas of business, such as the GMP audit sector.Following studies in Biology in Berlin and Münster, Martin Vortkamp's first post was as a Medical Affairs Manager with a contract research institution. He later moved to 3M and then to IVAX where, as Director of Commercial Development & Medical Affairs, he was responsible for Central Europe. The Biology graduate has been Director of Portfolio & Business Development at Teva Deutschland GmbH since 2006.
Since July 2009, Martin Vortkamp has assumed the role of Head of Business Development at Diapharm. The pharmaceutical service provider assists pharmaceutical and healthcare companies with all regulatory, medical and pharmaceutical matters. In Germany, Diapharm employs 100 people across its sites in Münster, Bielefeld, Oldenburg and Lübeck.
(Approx. 1100 characters)
Download (Format: PDF, 76.60 KB)
Martin Vortkamp is Diapharm's new Head of Business Development.
(Format: JPG, 234.22 KB, 300 DPI)
